Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.38 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | FASN | P49327 | 1/20 | 0.37 |
| ▸ | FEN1 | P39748 | 2/20 | 0.33 |
| ▸ | DPP4 | P27487 | 9/20 | 0.32 |
| ▸ | DPP7 | Q9UHL4 | 5/20 | 0.32 |
| ▸ | DPP9 | Q86TI2 | 5/20 | 0.32 |
| ▸ | DPP8 | Q6V1X1 | 3/20 | 0.32 |
| ▸ | KDM1A | O60341 | 2/20 | 0.31 |
| ▸ | MAOB | P27338 | 1/20 | 0.31 |
| ▸ | ALOX5AP | P20292 | 1/20 | 0.31 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.31 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18458840 | 0.88 | APP (0.36) | APPCYP3A4CYP2C9CYP2D6CYP2C19 | |
| SCHEMBL24372634 | 0.87 | CYP2C9 (0.43) | APPCYP3A4CYP2C9CYP2D6CYP2C19 | |
| SCHEMBL18866787 | 0.87 | FASN (0.41) | APPCYP3A4CYP2C9CYP2D6CYP2C19 | |
| SCHEMBL22652082 | 0.86 | FASN (0.41) | APPCYP3A4CYP2C9SPHK1CYP2D6 | |
| SCHEMBL20209657 | 0.85 | APP (0.36) | APPCYP3A4CYP2C9SPHK1CYP2D6 | |
| SCHEMBL18458594 | 0.85 | FASN (0.40) | APPCYP3A4CYP2C9SPHK1CYP2D6 | |
| SCHEMBL18458822 | 0.85 | SPHK1 (0.47) | CYP3A4CYP2C9SPHK1KDM1AMAOB | |
| SCHEMBL18458902 | 0.84 | DPP4 (0.34) | APPCYP3A4CYP2C9CYP2D6CYP2C19 | |
| SCHEMBL20209659 | 0.84 | APP (0.36) | APPCYP3A4CYP2C9SPHK1CYP2D6 | |
| SCHEMBL19619448 | 0.84 | APP (0.38) | APPCYP3A4CYP2C9CYP2D6CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11345857-B2 | Spontaneous alignment assistant for liquid crystal compositions | DIC CORPORATION (JP) | 2022-05-31 | — | — | US | disclosed |
| US-11326103-B2 | Liquid crystal display device | DIC CORPORATION (JP) | 2022-05-10 | — | — | US | disclosed |
| US-20210223635-A1 | METHOD FOR MANUFACTURING LIQUID CRYSTAL DISPLAY DEVICE | DIC CORPORATION (JP) | 2021-07-22 | — | — | US | disclosed |
| US-20210071084-A1 | SPONTANEOUS ALIGNMENT ASSISTANT FOR LIQUID CRYSTAL COMPOSITIONS | DIC CORPORATION (JP) | 2021-03-11 | — | — | US | disclosed |
| US-10927300-B2 | Spontaneous alignment assistant for liquid crystal compositions | DIC CORPORATION (JP) | 2021-02-23 | — | — | US | disclosed |
| US-20210026206-A1 | LIQUID CRYSTAL DISPLAY DEVICE | DIC CORPORATION (JP) | 2021-01-28 | — | — | US | disclosed |
| US-20200354633-A1 | LIQUID CRYSTAL DISPLAY ELEMENT | DIC CORPORATION (JP) | 2020-11-12 | — | — | US | disclosed |
| US-20200172811-A1 | LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | DIC CORPORATION (JP) | 2020-06-04 | — | — | US | disclosed |
| US-20200071617-A1 | LIQUID CRYSTAL DISPLAY ELEMENT | DIC CORPORATION (JP) | 2020-03-05 | — | — | US | disclosed |
| US-10414979-B2 | Composition and liquid crystal display device using the same | DIC CORPORATION (JP) | 2019-09-17 | — | — | US | disclosed |
| US-9822304-B2 | Liquid crystal composition and liquid crystal display element containing the same | DIC CORPORATION (JP) | 2017-11-21 | — | — | US | disclosed |
| US-20170306231-A1 | COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE USING THE SAME | DIC CORPORATION (JP) | 2017-10-26 | — | — | US | disclosed |
| US-20170253800-A1 | NEMATIC LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE USING THE SAME | DIC CORPORATION (JP) | 2017-09-07 | — | — | US | disclosed |
| US-20170226420-A1 | COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE USING THE SAME | DIC CORPORATION (JP) | 2017-08-10 | — | — | US | disclosed |
| US-20170210986-A1 | LIQUID CRYSTAL DISPLAY ELEMENT | DIC CORPORATION (JP) | 2017-07-27 | — | — | US | disclosed |
| US-20170210989-A1 | LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY ELEMENT USING THE SAME | DIC CORPORATION (JP) | 2017-07-27 | — | — | US | disclosed |
| US-9688913-B2 | Liquid crystal composition, liquid crystal display device, and liquid crystal display | DIC CORPORATION (JP) | 2017-06-27 | — | — | US | disclosed |
| US-9637684-B2 | Composition and liquid crystal display element using same | DIC CORPORATION (JP) | 2017-05-02 | — | — | US | disclosed |
| US-9580654-B2 | Liquid crystal composition and liquid crystal display device using the same | DIC CORPORATION (JP) | 2017-02-28 | — | — | US | disclosed |
| US-20170029700-A1 | LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY ELEMENT USING SAME | DIC CORPORATION (JP) | 2017-02-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11345857-B2 | Spontaneous alignment assistant for liquid crystal compositions | VAC14, VAPA, SFN | APP 1080/4885CYP3A4 4304/4885CYP2C9 4553/4885 |
| US-20210071084-A1 | SPONTANEOUS ALIGNMENT ASSISTANT FOR LIQUID CRYSTAL COMPOSITIONS | VAC14, VAPA, SFN | APP 1080/4885CYP3A4 4304/4885CYP2C9 4553/4885 |
| US-10927300-B2 | Spontaneous alignment assistant for liquid crystal compositions | KTN1, KCNA1, KNTC1 | APP 2148/4885CYP3A4 3865/4885CYP2C9 4406/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.